<html>
<head>PUBMED IDs for OV-1</head>
<body bgcolor='#C5F0F2'><h1>OV-1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7793069/'>Replicating foamy virus-based vectors directing high level expression of foreign genes.</a> June 20  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/7591274/'>Expression of p21WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma.</a> November 27  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/9018080/'>Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases.</a> December 20  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/14646525/'>Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines.</a> January 1  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/14646525/'>Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines.</a> January 1  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9009165/'>Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction.</a> January 17  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9815771/'>Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies.</a> June 1  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9409456/'>Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients.</a> December 31  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9472640/'>Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.</a> February 24  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9523734/'>In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems.</a> April 2  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9523731/'>Induction of DNA damage, inhibition of DNA synthesis and suppression of c-myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell line.</a> April 2  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10077643/'>Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro.</a> March 17  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10337661/'>Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture.</a> May 25  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10337631/'>Genomic structure of the human retinoic acid receptor-alpha1 gene.</a> May 25  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10337628/'>Mapping of the otogelin gene (OTGN) to mouse chromosome 7 and human chromosome 11p14.3: a candidate for human autosomal recessive nonsyndromic deafness DFNB18.</a> May 25  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10437915/'>Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: spontaneously mutant selection.</a> August 7  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10517638/'>A polycystic kidney-disease gene homologue required for male mating behaviour in C. elegans.</a> October 12  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10817511/'>Isolation and characterization of an IGROV-1 human ovarian cancer cell line made resistant to Ecteinascidin-743 (ET-743).</a> May 19  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10842200/'>Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase.</a> June 8  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10897038/'>Apoptosis induced by extracellular glutathione is mediated by H(2)O(2) production and DNA damage.</a> July 18  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10940933/'>Subcellular localization of intracellular protein tyrosine phosphatases in T cells.</a> August 15  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10970693/'>Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.</a> September 6  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11013075/'>Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor.</a> October 3  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11248058/'>Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.</a> March 15  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11641787/'>Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.</a> October 20  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11779836/'>Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.</a> January 10  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12411744/'>Towards understanding the polycystins.</a> November 2  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12411643/'>Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case.</a> November 2  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12411611/'>5' genomic structure of human Sp3.</a> November 2  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12598323/'>PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle.</a> February 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12629520/'>Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.</a> March 12  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12776159/'>Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies.</a> May 31  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12782587/'>Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting.</a> June 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12954713/'>Distinct roles of transcription factors EGL-46 and DAF-19 in specifying the functionality of a polycystin-expressing sensory neuron necessary for C. elegans male vulva location behavior.</a> September 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14657960/'>Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.</a> December 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15194000/'>Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells.</a> June 15  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15258697/'>Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A.</a> July 20  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15563610/'>ATP-2 interacts with the PLAT domain of LOV-1 and is involved in Caenorhabditis elegans polycystin signaling.</a> November 26  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15778465/'>Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.</a> March 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16076254/'>Interferon-alpha gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition.</a> August 4  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16166317/'>Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy.</a> September 17  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16258264/'>Induction of resistance to Aplidin in a human ovarian cancer cell line related to MDR expression.</a> November 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16319398/'>Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.</a> December 2  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16481400/'>Casein kinase II and calcineurin modulate TRPP function and ciliary localization.</a> February 17  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16801542/'>Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations.</a> June 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17079447/'>Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer.</a> November 3  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17354225/'>Aberrant regulation of argininosuccinate synthetase by TNF-alpha in human epithelial ovarian cancer.</a> March 14  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17455221/'>Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).</a> April 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17620309/'>Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.</a> July 11  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17985841/'>Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging.</a> November 8  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17985711/'>[Systems biology makes detailed understanding of complex diseases possible. Arteriosclerosis is an example].</a> November 8  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17985710/'>[Systems biology can radically change health care. Basis for individualized prediction, prevention and treatment].</a> November 8  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18028750/'>Comparative evaluation of the effects of statins on human stem and cancer cells in vitro.</a> November 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18279962/'>Defining targets of modulation of human tumor cell response to cisplatin.</a> February 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18340357/'>In vivo restoration of RhoB expression leads to ovarian tumor regression.</a> March 15  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18382425/'>Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes.</a> April 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18382388/'>Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features.</a> April 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18382384/'>An adenovirus type F41 outbreak in a pediatric bone marrow transplant unit: analysis of clinical impact and preventive strategies.</a> April 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18382382/'>Cytokine gene polymorphism in respiratory syncytial virus bronchiolitis.</a> April 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18682896/'>Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line.</a> August 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19240161/'>Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different origins.</a> June 9  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19288585/'>Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis.</a> July 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19368341/'>Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging.</a> July 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19478469/'>Molecular characterization of a new ovarian cancer cell line, YDOV-151, established from mucinous cystadenocarcinoma.</a> August 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19509545/'>Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.</a> September 26  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19769630/'>Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.</a> March 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19996280/'>Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity.</a> March 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20127029/'>Simultaneous confidence intervals to compare gene expression profiles using ABC transporter TaqMan microfluidic cards.</a> April 30  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20596667/'>ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139.</a> November 10  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20600897/'>A useful cell system for studying the regulation of 17HSD/KSR type 2 activity and expression in ovarian epithelial cancer.</a> November 4  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21078129/'>Strong cytotoxic effect of the bradykinin antagonist BKM-570 in ovarian cancer cells--analysis of the molecular mechanisms of its antiproliferative action.</a> January 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21081903/'>Inhibition of the inflammatory cytokine TNF-Î± increases adenovirus activity in ovarian cancer via modulation of cIAP1/2 expression.</a> August 31  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21734321/'>[Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro].</a> January 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21775057/'>Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.</a> October 26  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21878529/'>TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.</a> December 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22275115/'>Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro.</a> September 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22532440/'>Innate immune agonist, dsRNA, induces apoptosis in ovarian cancer cells and enhances the potency of cytotoxic chemotherapeutics.</a> October 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22717676/'>Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells.</a> November 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22792399/'>Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein.</a> January 11  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23484053/'>Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation.</a> September 4  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23484050/'>Crucial role of hyaluronan in neointimal formation after vascular injury.</a> September 4  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23484049/'>Genetic polymorphisms in Toll-like receptors among pediatric patients with renal parenchymal infections of different clinical severities.</a> September 4  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23913223/'>Proteomic profiling of ovarian cancer models using TMT-LC-MS/MS.</a> March 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23913215/'>Deep transcriptome profiling of ovarian cancer cells using next-generation sequencing approach.</a> March 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25032869/'>FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.</a> June 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26004777/'>Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1).</a> September 30  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26004768/'>Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.</a> October 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26474663/'>Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery.</a> September 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26474654/'>The -137G/C single nucleotide polymorphism in IL-18 gene promoter contributes to tuberculosis susceptibility in Chinese Han population.</a> August 18  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26732474/'>Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines.</a> October 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27554045/'>PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells.</a> August 25  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27554041/'>miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma.</a> February 1  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27671527/'>Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1.</a> September 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27671510/'>Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis.</a> March 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28404378/'>Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.</a> April 14  2017<br></body></html>
